GET /api/ms_vocab/?format=api&offset=12840&ordering=-name
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 43797,
    "next": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=12860&ordering=-name",
    "previous": "https://cinder.proteo.info/api/ms_vocab/?format=api&limit=20&offset=12820&ordering=-name",
    "results": [
        {
            "accession": "GO:0002573",
            "name": "myeloid leukocyte differentiation",
            "definition": "['The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0002274",
            "name": "myeloid leukocyte activation",
            "definition": "['A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000766",
            "name": "myeloid leukocyte",
            "definition": "['A cell of the monocyte, granulocyte, or mast cell lineage.']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:8692",
            "name": "myeloid leukemia",
            "definition": "['A leukemia that is located_in myeloid tissue.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0043011",
            "name": "myeloid dendritic cell differentiation",
            "definition": "['The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0001773",
            "name": "myeloid dendritic cell activation",
            "definition": "['The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000782",
            "name": "myeloid dendritic cell",
            "definition": "['A dendritic cell of the myeloid lineage.', 'These cells are CD1a-negative, CD1b-positive, CD11a-positive, CD11c-positive, CD13-positive, CD14-negative, CD20-negative, CD21-negative, CD33-positive, CD40-negative, CD50-positive, CD54-positive, CD58-positive, CD68-negative, CD80-negative, CD83-negative, CD85j-positive, CD86-positive, CD89-negative, CD95-positive, CD120a-negative, CD120b-positive, CD123-negative, CD178-negative, CD206-negative, CD207-negative, CD209-negative, and TNF-alpha-negative. Upon TLR stimulation, they are capable of producing high levels of TNF-alpha, IL-6, CXCL8 (IL-8).']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0002262",
            "name": "myeloid cell homeostasis",
            "definition": "['The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.']",
            "term_type": "cell line"
        },
        {
            "accession": "GO:0030099",
            "name": "myeloid cell differentiation",
            "definition": "['The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000763",
            "name": "myeloid cell",
            "definition": "['A cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000835",
            "name": "myeloblast",
            "definition": "['The most primitive precursor in the granulocytic series, having fine, evenly distributed chromatin, several nucleoli, a high nuclear-to-cytoplasmic ration (5:1-7:1), and a nongranular basophilic cytoplasm. They reside in the bone marrow.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000218",
            "name": "myelinating Schwann cell",
            "definition": "['A neuroglial cell of the peripheral nervous system which forms the insulating myelin sheaths of peripheral axons.']",
            "term_type": "cell line"
        },
        {
            "accession": "CL:0000328",
            "name": "myelin accumulating cell",
            "definition": "[]",
            "term_type": "cell line"
        },
        {
            "accession": "UBERON:0005290",
            "name": "myelencephalon",
            "definition": "['The posterior part of the developing vertebrate hindbrain or the corresponding part of the adult brain composed of the medulla oblongata and a portion of the fourth ventricle; as well as the glossopharyngeal nerve (CN IX), vagus nerve (CN X), accessory nerve (CN XI), hypoglossal nerve (CN XII), and a portion of the vestibulocochlear nerve (CN VIII).[BTO,WP].']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007917",
            "name": "MYC CT 9-B7.3 cell",
            "definition": "['disease: hybridoma']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007916",
            "name": "MYC CT 14-G4.3 cell",
            "definition": "['disease: hybridoma']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007915",
            "name": "MYC 1-9E10.2 cell",
            "definition": "['disease: hybridoma']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007914",
            "name": "MYB 2-7.77 cell",
            "definition": "['disease: hybridoma']",
            "term_type": "cell line"
        },
        {
            "accession": "CLO:0007913",
            "name": "MYB 2-3.76 cell",
            "definition": "['disease: hybridoma']",
            "term_type": "cell line"
        },
        {
            "accession": "DOID:437",
            "name": "myasthenia gravis",
            "definition": "[]",
            "term_type": "cell line"
        }
    ]
}